NEW YORK (

TheStreet

) --

Saul Centers

(BFS) - Get Report

was downgraded to sell at TheStreet Ratings.

Allergan

(NOK) - Get Report

was downgraded at Goldman Sachs. Valuation call, based on a $110 price target, Goldman said.

Big Lots

(BIG) - Get Report

wasdowngraded to hold at TheStreet Ratings.

CH Robinson

(CHRW) - Get Report

was downgraded at Goldman Sachs to sell from neutral. $56 price target. Light truck names should lag the broader group, Goldman said.

Facebook

(FB) - Get Report

was upgraded at UBS to buy from neutral. Price target goes to $30. Current valuation is low and new monetization efforts are encouraging, UBS said.

Forest Laboratories

(FRX)

was upgraded at Goldman Sachs to buy from neutral. $50 price target. See a higher potential for management to explore strategic options, Goldman said.

Fulton Financial

(FULT) - Get Report

was downgraded at Credit Suisse to underperform from neutral. $9.50 price target. Expect negative revisions to mortgage banking estimates, Credit Suisse said.

Also see: The 5 Dumbest Things on Wall Street>>

Kimberly-Clark

(KMB) - Get Report

was upgraded at BMO Capital Markets to market perform from underperform. Valuation call, based on a $96 price target, BMO Capital Markets said.

Medicines Company

(MDCO) - Get Report

was downgraded at Oppenheimer to perform from outperform. New analyst believes the stock is fully valued, Oppenheimer said.

Netgear

(NTGR) - Get Report

was upgraded at Wedbush to outperform from neutral. $38 price target. Company has potential catalysts for the second half and 2014, Wedbush said.

Questcor

(QCOR)

was downgraded at Bank of America/Merrill Lynch to neutral from buy. $51 price target. Acthar could face increased competition, BofA/Merrill said.

Also see: It's Time to Believe in Ciena>>

Questcor was upgraded at Oppenheimer to outperform from perform. $57 price target. New analyst believes that Acthar can drive near-term growth, Oppenheimer said.

Southern Company

(SO) - Get Report

was upgraded at Citigroup to buy from neutral. The GP rate case will be manageable, and Vogtle cost overruns do not present a structural issue, Citi said.

SPX

(SPW)

was downgraded at Citigroup to sell from neutral. Price target is $68. There is significant second half earnings risk and valuation is elevated, Citigroup said.

Total System

(TSS) - Get Report

was upgraded to outperform at Wells Fargo. Company shows unanticipated FCF growth and trades at a cheap multiple, Wells Fargo said.

Wendy's

(WEN) - Get Report

was initiated with a market perform rating at Wells Fargo. Company shows low EV/EBITDA relative its peers, but is inhibited by less-than-expected margin expansion, Wells Fargo said.

STOCK COMMENTS/EPS CHANGES

FirstMerit

(FMER)

numbers were raised at UBS. Estimates were increased to reflect the earlier-than-expected closing of the CRBC acquisition, said UBS. Price target goes to $22.

Corning

(GLW) - Get Report

numbers were reduced at UBS. Reflect LCD panel price declines and volume reductions, said UBS. Price target goes to $16.50.

Oracle

(ORCL) - Get Report

numbers were reduced at UBS. Earnings estimates were cut given a weak macro and concerns about the shift to the cloud and sales execution, said UBS. Price target goes to $37.

Oracle estimates were cut at Citigroup. Earnings estimates were reduced given macro weakness, said Citigroup. Price target remains $38.

Also see: The Return of the 10% Down Payment>>

Oracle estimates, price target were reduced at Oppenheimer. Shares are now seen reaching $37. Estimates were also cut, as the company is not executing well, Oppenheimer said. Outperform rating.

Supervalu

(SVU)

numbers were raised at Citigroup. Opportunity for cost savings and SG&A leverage, said Citigroup. Price target goes to $7.

>To submit a news tip, email:

tips@thestreet.com

.

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.